Search Results

Therapeutic Interventions for Pseudomonas Infections in Cystic Fibrosis Patients: A Review of Phase IV Trials.

• Authors : Alqasmi, Mohammed

Subjects: PSEUDOMONAS diseases; CYSTIC fibrosis; PSEUDOMONAS aeruginosa

• Source: Journal of Clinical Medicine; Nov2024, Vol. 13 Issue 21, p6530, 21p

Record details

What do We Know so Far about Ges Carbapenemases, and What Threat do They Pose?

• Authors : Rutkowski, Kamil; Osnytskyy, Anton; Ślifierska, Magdalena

Subjects: DRUG resistance in bacteria; AMINO acid sequence; BACTERIAL enzymes

• Source: Advancements of Microbiology; Sep2024, Vol. 63 Issue 3, p131-142, 12p

Record details

Tobramycin

• Authors : Gálvez-Acebal Juan; Rodríguez-Baño Jesús

• Source: Kucers' The Use of Antibiotics: A Clinical Review of Antibacterial, Antifungal and Antiviral Drugs.

Record details

Antibacterial Efficacy of Liposomal Formulations Containing Tobramycin and N -Acetylcysteine against Tobramycin-Resistant Escherichia coli , Klebsiella pneumoniae , and Acinetobacter baumannii.

• Authors : Alarfaj, Reem E.^1,2 (AUTHOR) ; Alkhulaifi, Manal M.¹ (AUTHOR) ; Al-Fahad, Ahmed J.³ (AUTHOR)

Subjects: *ACINETOBACTER baumannii; *TOBRAMYCIN; *KLEBSIELLA pneumoniaeAMES (Iowa)

• Source: Pharmaceutics. Jan2022, Vol. 14 Issue 1, p130-130. 1p.

Record details

Lytic Bacteriophage Is a Promising Adjunct to Common Antibiotics across Cystic Fibrosis Clinical Strains and Culture Models of Pseudomonas aeruginosa Infection.

• Authors : Martin, Isaac; Morales, Sandra; Alton, Eric W. F. W.

Subjects: PSEUDOMONAS aeruginosa infections; CYSTIC fibrosis; ANTIBIOTICS

• Source: Antibiotics (2079-6382); Mar2023, Vol. 12 Issue 3, p593, 14p

Record details

Antimicrobial Resistance in Rapidly Growing Nontuberculous Mycobacteria among Domestic and Wild Animals Emphasizing the Zoonotic Potential.

• Authors : Reil, Irena; Špičić, Silvio; Barbić, Ljubo

Subjects: CLARITHROMYCIN; DOMESTIC animals; DRUG resistance in microorganisms

• Source: Microorganisms; Oct2023, Vol. 11 Issue 10, p2520, 10p

Record details

Risk factors for development of aminoglycoside resistance among gram-negative rods.

• Authors : Richter, Stefan E; Miller, Loren; Needleman, Jack

Subjects: ANTI-infective agents; CYSTIC fibrosis diagnosis; AMINOGLYCOSIDES

• Source: American Journal of Health-System Pharmacy. 11/15/2019, Vol. 76 Issue 22, p1838-1847. 10p. 4 Charts, 1 Graph.

Record details

Novel glycopolymer sensitizes Burkholderia cepacia complex isolates from cystic fibrosis patients to tobramycin and meropenem.

• Authors : Narayanaswamy, Vidya P.; Giatpaiboon, Scott; Baker, Shenda M.

Subjects: CYSTIC fibrosis treatment; BURKHOLDERIA cepacia; TOBRAMYCIN

• Source: PLoS ONE; 6/29/2017, Vol. 12 Issue 6, p1-12, 12p

Record details

Analysis of virulence phenotypes and antibiotic resistance in clinical strains of Acinetobacter baumannii isolated in Nashville, Tennessee.

• Authors : Boone, Ranashia L.; Whitehead, Briana; Avery, Tyra M.

Subjects: DRUG resistance in bacteria; ACINETOBACTER baumannii; MEROPENEMNASHVILLE (Tenn.)

• Source: BMC Microbiology; 1/9/2021, Vol. 21 Issue 1, p1-12, 12p

Record details

Overcoming Multidrug Resistance in Salmonella spp. Isolates Obtained From the Swine Food Chain by Using Essential Oils: An in vitro Study.

• Authors : Lauteri, Carlotta; Maggio, Francesca; Serio, Annalisa

Subjects: ESSENTIAL oils; MULTIDRUG resistance; TETRACYCLINE

• Source: Frontiers in Microbiology; 2/9/2022, Vol. 13, p1-11, 11p

Record details